Octave Specialty (OSG) Cost of Revenue (2021 - 2026)

Octave Specialty's Cost of Revenue history runs 6 years deep, the most recent figure standing at $19.7 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 87.49% year-over-year to $19.7 million; the TTM figure through Mar 2026 stood at $56.4 million (down 11.59% YoY), while the FY2025 annual figure was $47.2 million, down 35.02% from the prior year.
• Cost of Revenue for Q1 2026 stood at $19.7 million, up from $11.3 million in the prior quarter.
• The five-year high for Cost of Revenue was $353.0 million in Q3 2022, with the low at -$331.9 million in Q4 2022.
• The 5-year median for Cost of Revenue is $12.0 million (2022), against an average of $13.7 million.
• Peak annual rise in Cost of Revenue reached 541.82% in 2022, while the deepest fall reached 354.7% in 2022.
• Octave Specialty's Cost of Revenue stood at -$331.9 million in 2022, then jumped by 105.06% to $16.8 million in 2023, then tumbled by 41.53% to $9.8 million in 2024, then grew by 15.34% to $11.3 million in 2025, then jumped by 73.64% to $19.7 million in 2026.
• Business Quant data shows OSG's Cost of Revenue at $19.7 million in Q1 2026, $11.3 million in Q4 2025, and $14.4 million in Q3 2025.